Risk factors in patients with refractory peptic ulcer

被引：0

作者：

Massarrat, S

机构：

[1] Department of Gastroenterology, Tehran Univ. of Medical Sciences, Shariati Hospital, Tehran, Kargar Shomali Avenue

来源：

GASTROENTEROLOGY | 1996年 / 111卷 / 01期

关键词：

D O I：

10.1053/gast.1996.v111.agast961110267

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：267 / 267

页数：1

相关论文

共 8 条

[1] REFRACTORY DUODENAL-ULCER
BARDHAN, KD
[J]. GUT, 1984, 25 (07) : 711 - 717
[2] CLASSEN M, 1985, HEPATO-GASTROENTEROL, V32, P243
[3] RISK-FACTORS ASSOCIATED WITH REFRACTORY PEPTIC-ULCERS
LANAS, AI
REMACHA, B
ESTEVA, F
SAINZ, R
[J]. GASTROENTEROLOGY, 1995, 109 (04) : 1124 - 1133
[4] RISK-FACTORS FOR HEALING OF DUODENAL-ULCER UNDER ANTACID TREATMENT - DO ULCER PATIENTS NEED INDIVIDUAL TREATMENT
MASSARRAT, S
MULLER, HG
SCHMITZMOORMANN, P
[J]. GUT, 1988, 29 (03) : 291 - 297
[5] FACTORS AFFECTING THE HEALING RATE OF DUODENAL AND PYLORIC ULCERS WITH LOW-DOSE ANTACID TREATMENT
MASSARRAT, S
EISENMANN, A
[J]. GUT, 1981, 22 (02) : 97 - 102
[6] DUODENAL-ULCERS RESISTANT TO H-2 BLOCKERS - AN EMERGING THERAPEUTIC PROBLEM
PORRO, GB
PARENTE, F
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 81 - 88
[7] PORRO GB, 1990, MECH PEPTIC ULCER HE, P249
[8] POUNDER RE, 1987, ALIMENT PHARM THERAP, V1, P439